Literature DB >> 10928353

Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum.

J Krungkrai1, D Burat, S Kudan, S Krungkrai, P Prapunwattana.   

Abstract

The two developmental stages of human malarial parasite Plasmodium falciparum, asexual and sexual blood stages, were continuously cultivated in vitro. Both asexual and sexual stages of the parasites were assayed for mitochondrial oxygen consumption by using a polarographic assay. The rate of oxygen consumption by both stages was found to be relatively low, and was not much different. Furthermore, the mitochondrial oxygen consumption by both stages was inhibited to various degrees by mammalian mitochondrial inhibitors that targeted each component of complexes I- IV of the respiratory system. The oxygen consumption by both stages was also affected by 5-fluoroorotate, a known inhibitor of enzyme dihydroorotate dehydrogenase of the pyrimidine pathway and by an antimalarial drug atovaquone that acted specifically on mitochondrial complex III of the parasite. Moreover, antimalarials primaquine and artemisinin had inhibitory effects on the oxygen consumption by both stages of the parasites. Our results suggest that P. falciparum in both developmental stages have functional mitochondria that operate a classical electron transport system, containing complexes I-IV, and linked to the pyrimidine biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10928353

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  19 in total

1.  ATP synthase complex of Plasmodium falciparum: dimeric assembly in mitochondrial membranes and resistance to genetic disruption.

Authors:  Praveen Balabaskaran Nina; Joanne M Morrisey; Suresh M Ganesan; Hangjun Ke; April M Pershing; Michael W Mather; Akhil B Vaidya
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 2.  Plasmodium drug targets outside the genetic control of the parasite.

Authors:  David J Sullivan
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 3.  Central carbon metabolism of Plasmodium parasites.

Authors:  Kellen L Olszewski; Manuel Llinás
Journal:  Mol Biochem Parasitol       Date:  2010-09-16       Impact factor: 1.759

4.  Neurotoxic mode of action of artemisinin.

Authors:  Gabriele Schmuck; Elke Roehrdanz; Richard K Haynes; Regine Kahl
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.

Authors:  Patricia Ferrer; Joel Vega-Rodriguez; Abhai K Tripathi; Marcelo Jacobs-Lorena; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

6.  A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.

Authors:  Tomoyo Sakata-Kato; Dyann F Wirth
Journal:  ACS Infect Dis       Date:  2016-10-25       Impact factor: 5.084

Review 7.  Isoprenoid biosynthesis in Plasmodium falciparum.

Authors:  Ann M Guggisberg; Rachel E Amthor; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2014-09-12

Review 8.  Discovery, mechanisms of action and combination therapy of artemisinin.

Authors:  Liwang Cui; Xin-zhuan Su
Journal:  Expert Rev Anti Infect Ther       Date:  2009-10       Impact factor: 5.091

9.  Proteomic analysis revealed alterations of the Plasmodium falciparum metabolism following salicylhydroxamic acid exposure.

Authors:  Marylin Torrentino-Madamet; Lionel Almeras; Christelle Travaillé; Véronique Sinou; Matthieu Pophillat; Maya Belghazi; Patrick Fourquet; Yves Jammes; Daniel Parzy
Journal:  Res Rep Trop Med       Date:  2011-09-08

10.  Global response of Plasmodium falciparum to hyperoxia: a combined transcriptomic and proteomic approach.

Authors:  Marylin Torrentino-Madamet; Lionel Alméras; Jérôme Desplans; Yannick Le Priol; Maya Belghazi; Matthieu Pophillat; Patrick Fourquet; Yves Jammes; Daniel Parzy
Journal:  Malar J       Date:  2011-01-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.